situation will end, the company was also affected in the 1st quarter too. Starting with China as the beginning of outbreak, the government has locked down the country and ordered the cease operation in both
, agreeing to comply with the civil sanctions, or upon the expiry of the period of prohibiting them from holding the positions of director or executive of the company, as ordered by the SEC pursuant to the
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
flexible packaging lines are ordered from multiple vendors, there is a risk of delays in ordering components to integrate into complete production line. The installation of the main machine components must
(minute/s Postpaid Prepaid Blended VOU (GB/data s Postpaid Prepaid Blended Device Penetrat 4G‐handset Fixed Broadban FBB subscri FBB net add FBB ARPU ( 1H17 Snap For 1H17, AIS (excluding IC
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
% Blended 18.0 22.6 24.9 38% 10% Device Penetration 4G-handset penetration 77% 81% 80% - - Fixed Broadband Business FBB subscribers 1,336,900 1,668,900 001,772, 0 33% 6.2% FBB net addition 81,400 133,000